Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome


Immune-mediated, non-communicable diseases, such as autoimmune diseases, allergic diseases and asthma, are chronic disorders in which the immune system plays a pivotal role. The World Health Organisation (WHO) has highlighted the seriousness of autoimmunity and its association with exposure to the environment. 

EXIMIOUS aims to deliver a new way of assessing the human exposome, i.e. the exposures to environmental factors that one experiences throughout life, and shed light on its association to immune-mediated diseases.


EXIMIOUS is part of the European Human Exposome Network and brings together 15 partner organisations from 7 European countries.


Don’t know what the exposome is?

Want to know more about exposure-related immune diseases?

Curious to know more about what to expect from this project?

Project facts

EXIMIOUS is a 5 year Research and Innovation Action funded by the European Union’s Horizon 2020 programme.

Latest news

Partner in the spotlight: VHIR

We’re glad to welcome the New Year by continuing our partner in the spotlight series. Under the spotlight today is the Vall d’Hebrón Research Institute (VHIR).

Partner in the spotlight: accelopment Schweiz AG

This month we’re pleased to introduce accelopment Schweiz AG, our EXIMIOUS partner in the lead for the project’s communication, dissemination and exploitation . Based in Zürich, Switzerland, accelopment has been a sparring partner in the acquisition, management and communication and dissemination support of EU funded projects for research and innovation since 2008.

Latest Tweets

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874707.